Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-12-045889

← back to feed
Filed
Aug 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 13, 2012 21.63M sh
Stockholders Equity Q2 2012 · Jun 30, 2012 −$996.16K
Stockholders Equity Q2 2012 · Dec 31, 2011 −$124.03K
Current Liabilities Q2 2012 · Jun 30, 2012 $2.3M
Current Liabilities Q2 2012 · Dec 31, 2011 $2.31M
Current Assets Q2 2012 · Jun 30, 2012 $1.3M
Current Assets Q2 2012 · Dec 31, 2011 $2.18M
Total Assets Q2 2012 · Jun 30, 2012 $1.31M
Total Assets Q2 2012 · Dec 31, 2011 $2.19M
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$773.12K
Cash And Equivalents Q2 2012 · Jun 30, 2011 $2.75M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $3.52M
Sga Expense Q2 2012 · Jun 30, 2011 $373K
Sga Expense Q2 2012 · Jun 30, 2011 $669.35K
Rd Expense Q2 2012 · Jun 30, 2011 $179.94K
Rd Expense Q2 2012 · Jun 30, 2011 $341.99K
Operating Income Q2 2012 · Jun 30, 2011 −$552.94K
Operating Income Q2 2012 · Jun 30, 2011 −$1.01M
Revenue Q2 2012 · Jun 30, 2011 $0
Revenue Q2 2012 · Jun 30, 2011 $0